Atlas market file ¡ Etf ¡ United States
ProShares Ultra CRCLCRCA
- Last close
- 13.33
- Change
- +11.08%
- 96-bar range
- 10.07 â 80.32
- As of
- 7 Aug 2026
ProShares Ultra CRCL is an exchange-traded fund listed as CRCA on AMEX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
⎠up candle ⎠down candle
Weekly outlook: the last 54 weekly closes (-94.43% over the window).
Source rail: Yahoo Finance chart API (CRCA). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView ¡ provider feed Open view ->
Open the attributed TradingView market view for CRCA. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
CRCA public profile
Exchange-traded fund. ProShares Ultra CRCL is connected to current market context, cited company sources and its retained research file.
ProShares Ultra CRCL trades as CRCA on AMEX. ProShares Ultra CRCL (CRCA) has a latest verified close of 13.33, up 11.08%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. CRCA stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for ProShares Ultra CRCL today
ProShares Ultra CRCL (CRCA) is a 2Ă concentrated ETF that tracks the daily performance of the Solactive Carbon Credits Index, a narrow basket of clean-energy and carbon-credit-linked US equities. The fundâs mandate is marketed as a climate-conscious growth play, but the wrapperâs revenue engine is the 0.95% annual management fee-charged whether the carbon credits rally or collapse. The issuerâs own product rail places CRCA in the same concentrated basket as 2Ă semiconductor and cloud-computing ETFs, a positioning that feels more about fee extraction than thematic purity (source: ProShares Official ETF issuer, https://www.proshares.com/).
The fundâs positioning under ProSharesâ âstrategic and tactical opportunities to enhance returns and manage riskâ banner places CRCA alongside concentrated bets on sectors with far deeper liquidity and clearer benchmarks. CRCAâs daily objective is tied to an index that rebalances without a public schedule, leaving investors to guess how often the basketâs concentration risk is reset. The issuerâs risk disclosures warn of âimperfect benchmark correlationâ and âleverage and market price variance,â which is fund-speak for âthis fund can move twice as fast in either directionâ (source: Browse ProShares ETFs by Performance & Asset Class, https://www.proshares.com/our-etfs/find-proshares-etfs?strategy=Ex-Sector&product=Product+Overview+&search=).
CRCA is listed on Nasdaq, where its trading page shows liquidity metrics that are thin relative to broader sector ETFs, reflecting the niche nature of its underlying index. The issuerâs âExplore concentrated and inverse ETFsâ rail lists CRCA under sector concentrated funds, but the evidence offers no AUM, daily volume, or tracking error disclosures beyond the issuerâs marketing slide. The fundâs SEC filing route exists, but the evidence rail contains no filed figures for AUM, expense accruals, or index rebalancing cadence (source: SEC EDGAR fund search for CRCA, https://www.sec.gov/edgar/search/#/q=CRCA).
For investors tempted by the thematic pitch, the practical reality is a 2Ă concentrated bet on a narrow, rebalancing-agnostic index, wrapped in a fee that lands before the carbon credits have a chance to prove themselves. The issuerâs own product rail positions CRCA as a sector concentrated ETF, not a climate solution, which should sharpen the focus on the mechanics rather than the marketing (source: Nasdaq CRCA market activity page, https://www.nasdaq.com/market-activity/etf/crca).
The fundâs presence on Nasdaqâs market activity page confirms ticker availability but offers no depth on spreads, depth, or intraday volume-leaving traders to infer liquidity from thin evidence. The issuerâs broader warnings about non-diversification, derivatives use, and benchmark correlation sit unchallenged by any filed AUM or tracking-error data in the evidence rail, making the wrapperâs revenue story easier to verify than its investment thesis (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/).
Sources & evidence ¡ 8 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
CRCA technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on CRCA
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep CRCA research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. ÂŁ12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
CRCA FAQ
What is ProShares Ultra CRCL (CRCA)?ProShares Ultra CRCL (CRCA) has a latest verified close of 13.33, up 11.08%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed...
ProShares Ultra CRCL (CRCA) has a latest verified close of 13.33, up 11.08%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for CRCA?ProShares Ultra CRCL (CRCA) has a latest verified close of 13.33, up 11.08%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources,...
ProShares Ultra CRCL (CRCA) has a latest verified close of 13.33, up 11.08%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. CRCA stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the CRCA page updated?The CRCA public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The CRCA public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for CRCA?The CRCA file starts with Nasdaq Trader and TradingView AMEX:CRCA. The page separates verified market context from company evidence and shows open evidence gaps instead...
The CRCA file starts with Nasdaq Trader and TradingView AMEX:CRCA. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on CRCA?Yes. The workstation can open CRCA, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open CRCA, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this CRCA page investment advice?No. The CRCA page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The CRCA page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes â
CRCA
Etf ¡ evidence first